Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 12/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.42 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17280828 | 0.93 | SLC7A5 (0.63) | SLC7A5SLC6A4SLC6A2SLC6A3KCNK2 | |
| SCHEMBL17280834 | 0.87 | SLC7A5 (0.58) | SLC7A5SLC6A4SLC6A2SLC6A3HRH3 | |
| SCHEMBL17280857 | 0.85 | SLC7A5 (0.71) | SLC7A5SLC6A4SLC6A2SLC6A3KCNK2 | |
| SCHEMBL17280858 | 0.85 | SLC7A5 (0.71) | SLC7A5SLC6A4SLC6A2SLC6A3KCNK2 | |
| SCHEMBL17278094 | 0.85 | SLC7A5 (0.71) | SLC7A5SLC6A4SLC6A2SLC6A3KCNK2 | |
| SCHEMBL17278097 | 0.85 | SLC7A5 (0.72) | SLC7A5SLC6A4SLC6A2SLC6A3KCNK2 | |
| SCHEMBL17278124 | 0.85 | SLC7A5 (0.76) | SLC7A5SLC6A4SLC6A2SLC6A3KCNK2 | |
| SCHEMBL17280831 | 0.84 | SLC7A5 (0.69) | SLC7A5SLC6A4SLC6A2SLC6A3KCNK2 | |
| SCHEMBL17280826 | 0.84 | SLC7A5 (0.76) | SLC7A5SLC6A4SLC6A2SLC6A3KCNK2 | |
| SCHEMBL17278114 | 0.83 | SLC7A5 (0.78) | SLC7A5SLC6A4SLC6A2SLC6A3KCNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9771316-B2 | Phenoxyalkylamine compound | OSAKA UNIVERSITY (JP) | 2017-09-26 | — | — | US | disclosed |
| US-20150336876-A1 | PHENOXYALKYLAMINE COMPOUND | KNC LABORATORIES CO., LTD. (JP) | 2015-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150336876-A1 | PHENOXYALKYLAMINE COMPOUND | LATS1, LATS2, SHC1 | SLC7A5 63/4885SLC6A4 413/4885SLC6A2 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.